USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS NK-1
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated...
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
11.08.2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent. |
|---|---|
| AbstractList | The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent. |
| Author | LARRICK, James, W PERLMAN, Andrew, J ZHANG, Xiaoming SCHNIPPER, Edward, F |
| Author_xml | – fullname: SCHNIPPER, Edward, F – fullname: PERLMAN, Andrew, J – fullname: ZHANG, Xiaoming – fullname: LARRICK, James, W |
| BookMark | eNrjYmDJy89L5WSwCQ12VfB3U_Dz1jVUCHJ1dg0I8Q9ScPQLcXT39_MMDlEIdg3y8Q_wDAEKKXj6KQQEhQZ5hoQGgzXwMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ4D29DIyNjCyMDR0NjIpQAAKauKq8 |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 受體拮抗劑司洛匹坦在瘙癢中的用途 |
| ExternalDocumentID | HK1223820A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_HK1223820A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:48:41 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_HK1223820A13 |
| Notes | Application Number: HK20160111172 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170811&DB=EPODOC&CC=HK&NR=1223820A1 |
| ParticipantIDs | epo_espacenet_HK1223820A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20170811 |
| PublicationDateYYYYMMDD | 2017-08-11 |
| PublicationDate_xml | – month: 08 year: 2017 text: 20170811 day: 11 |
| PublicationDecade | 2010 |
| PublicationYear | 2017 |
| RelatedCompanies | MENLO THERAPEUTICS INC |
| RelatedCompanies_xml | – name: MENLO THERAPEUTICS INC |
| Score | 3.2217214 |
| Snippet | The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS NK-1 |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170811&DB=EPODOC&locale=&CC=HK&NR=1223820A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_St6Lp2q4Fi2z9sLWsLW0qextdP3Av23AVwb_eS-mmL_oWLslxCVx-d5fcBeBOkUpFV_VMzNGzFmVVksUMcUKsck3TpYfBQB7y5ORJoLqp_DJVph1YbHNhmjqhn01xRNSoHPW9bs7r9U8Qy2reVm7u5wskrZ4cZlhC6x3TISIcFayxYUehFZqCaRquLwSxQREGEexG6CjtcSual9m3X8c8KWX9G1GcY9iPkNmyPoHO11sPDs3tx2s9OJi0993YbFVvcwqPaWKT0CGBL1IS26YdsTAmo4CNnsPASxhJ0C4NI48hiXgBieI09liaNBPOgDg2M10RxZjtljxz_Z3Ag3PoLlfL8gII2nJ6NtcKmhWKXOWZXvKLsUoqtAqHFkUf-n-yufyn7wqO-N7xUCml19Ct3z_KG8Taen7b7NI3ID18vQ |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2J97kFyC7pp0iZgkDYPE9MmIdlIbyXNA3tpi40I_nonS1u96G2ZfTC7MPvtN7szC3CnSIWi9bRUzJBZi3JPksUUcUIsM1XVpIduV-7Xwcljv-ck8stEmTRgvo2F4XlCP3lyRLSoDO294vv16seJZfK3lev72RxFyyeb6aawYce0jwhHBXOoW2FgBoZgGLrjCX6kU4RBBLsBEqW9PjJCzpReh3VQyuo3othHsB_iYIvqGBpfb21oGduP19pwMN7cd2NxY3rrE3hMYosENvE9kZLIMqyQBREZ-GzwHPhuzEiM59IgdBmKiOuTMEoilyUx73AKxLaY4YioxnQ35anj7RTunkFzsVwU50DwLKelMzWnaa7IZZZqRX0xVkq5WmLTPO9A589hLv6pu4WWw8aj6cj1vUs4rNexdptSegXN6v2juEbcrWY3fMW-ARoff6c |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+NK-1+RECEPTOR+ANTAGONIST+SERLOPITANT+IN+PRURITUS+NK-1&rft.inventor=SCHNIPPER%2C+Edward%2C+F&rft.inventor=PERLMAN%2C+Andrew%2C+J&rft.inventor=ZHANG%2C+Xiaoming&rft.inventor=LARRICK%2C+James%2C+W&rft.date=2017-08-11&rft.externalDBID=A1&rft.externalDocID=HK1223820A1 |